51. Decreased 1,25-dihydroxycholecalciferol and increased 25-hydroxy- and 24,25-dihydroxycholecalciferol in tissues of rats treated with thyroxine
- Author
-
Samuel Edelstein, Yosef Weisman, R Lubelski, Zvi Spirer, Arie Harell, and Zipora Eisenberg
- Subjects
Male ,medicine.medical_specialty ,24,25-Dihydroxyvitamin D 3 ,Endocrinology, Diabetes and Metabolism ,Kidney ,Hyperthyroidism ,chemistry.chemical_compound ,Endocrinology ,Calcitriol ,Internal medicine ,Vitamin D and neurology ,medicine ,Animals ,Orthopedics and Sports Medicine ,Intestinal Mucosa ,Calcifediol ,Cholecalciferol ,Calcium metabolism ,Hydroxycholecalciferols ,Kidney metabolism ,Rats, Inbred Strains ,Metabolism ,Rats ,Thyroxine ,Liver ,chemistry ,Sephadex ,Dihydroxycholecalciferols ,lipids (amino acids, peptides, and proteins) ,24,25-Dihydroxycholecalciferol - Abstract
The effect of thyroxine on the metabolism of vitamin D was investigated in rats. Vitamin D depleted rats were repleted by injections of radiolabelled cholecalciferol or 25-hydroxycholecalciferol (25OHD3). After 3 weeks, a state of hyperthyroidism was induced by daily injections of L-thyroxine for 21 days. The lipid extracts of the Plasma and tissues were analyzed by successive Sephadex LH-20 and high pressure liquid chromatography. The concentrations of 25OHD3 and of 24,25-dihydroxycholecalciferol (24,25 (OH)2D3) were significantly higher and those of cholecalciferol and of 1,25-dihydroxycholecalciferol (1,25(OH)2D3) were significantly lower in the plasma and tissues of animals treated with thyroxine than in controls. The present study suggests that alterations in the metabolism of vitamin D may be involved in the disturbances of calcium metabolism observed in hyperthyroidism.
- Published
- 1981